Genoox (an QIAGEN company)
Digital Health — Stage: . Est: 2025. Tags: Analytics, Artificial Intelligence, Big Data, Bioinformatics, Cloud, Data Management, Data Storage, Diagnostics, Digital Health, Genomics, Healthtech, Insights, Life Sciences, Machine Learning, MedTech, Precision Medicine, SaaS. Genoox, now part of QIAGEN, is a genomic data and AI platform transforming NGS data into actionable insights for clinicians, biopharma, and payers globally. Its Franklin platform uses AI to analyze and interpret genomic variants, integrating public, proprietary, and community-curated evidence to enhance clinical decisions and enable targeted therapies. By operationalizing the Actionable Genome™ technology, Genoox boosts diagnostic yield and streamlines reporting in clinical genetics workflows. Serving 1,700+ organizations across 44 markets, it offers a vendor-neutral, cloud-based model. QIAGEN, a Netherlands-based holding company, is a leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life.. Web: https://www.genoox.com